PALISADE BIO, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Palisade Bio, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2016 to Q3 2024.
  • Palisade Bio, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.5M shares, a 206% increase year-over-year.
  • Palisade Bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.84M shares, a 677% increase from 2022.
  • Palisade Bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 880K shares, a 371% increase from 2021.
  • Palisade Bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 187K shares, a 93.3% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.5M +1.01M +206% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 1.23M +801K +187% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 768K +480K +167% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 6.84M +5.96M +677% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 490K -485K -49.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 428K +22K +5.41% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 288K -36.8K -11.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 880K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 974K -11.1M -92% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 406K -8.58M -95.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 324K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 12.1M +9.33M +336% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 8.98M +6.21M +224% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q3 2020 2.77M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 2.77M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q3 2018 15.2M +1.01M +7.12% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-14
Q3 2017 14.2M +5.33M +60.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q3 2016 8.84M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.